Removal of Remdesivir’s Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19

Remdesivir has reported efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro and in vivo. Drug-drug interactions limit therapeutic options in transplant patients. Remdesivir and its metabolite GS-441524 are excreted principally in urine. In intensive care unit (ICU)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Lê, Minh Patrick, Le Hingrat, Quentin, Jaquet, Pierre, Wicky, Paul-Henri, Bunel, Vincent, Massias, Laurent, Visseaux, Benoit, Messika, Jonathan, Descamps, Diane, Mal, Hervé, Timsit, Jean-François, Peytavin, Gilles
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577145/
https://ncbi.nlm.nih.gov/pubmed/32868327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01521-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados